Thalidomide and thrombosis.
Mehta
Paulette
P
University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004354:Drug Screening Assays, Antitumor; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use; D013927:Thrombosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D013792:Thalidomide; D014859:Warfarin; D006493:Heparin